Indonesian herbal diabetic drug to target EU and Asia
Indonesian herbal drug specialist Dexa Laboratories will push its natural diabetic product into European and wider Asian markets, following success in its domestic market.
Indonesian herbal drug specialist Dexa Laboratories will push its natural diabetic product into European and wider Asian markets, following success in its domestic market.
FloraGLO lutein supplier Kemin has bolstered its presence in the eye health market with a deal to secure exclusive access to a natural source of potent yellow antioxidant zeaxanthin.
The European islands of Guernsey and Jersey are working together to bring them into compliance with European Union laws on claims, labelling and formulation.
Norwegian krill ingredient supplier Olympic Seafood AS has kicked off a new research partnership to investigate the fundamental science behind krill phospholipids.
A new high-content lupin cereal holds huge potential for the global health and gluten-free markets, according to its Australian developers.
Carotenoid player Kemin has announced the exclusive licensing of naturally-sourced zeaxanthin from marigolds.
Supplement maker Nutrex Research has hit back at allegations made in two class action lawsuits filed in the wake of the FDA crackdown on controversial pre-workout stimulant DMAA (1,3-Dimethylamylamine).